Posts

ASH 2020 | Talking with Prof. Steven Pipe about lymphoma therapy

ASH2020 | Dr. Diletta Fontana: Obtain more insights into the molecular mechanisms governing aCML development and progression is important

ASH 2020 | Talking with Professor Mark Roschewski about lymphoma therapy

ASH 2020 【Expert connection】| Discussion among Prof. Shaji Kumar and Prof. Liang Wang: focus on relapsed/refractory multiple myeloma drug resistance and research progress

Prof. Nikhil Munishi: High-throughput gene analysis has brought new methods for diagnosis and prognosis assessment, and immunotherapy is setting off a new wave of MM therapy

ASH 2020 | Prof. Eunice Wang: Recent advances in the treatment of AML

ASH 2020 | Prof. Ruben Mesa: The latest research progress in MPN field, and How should disease-related care for MPN patients are managed in this phenomenon?

ASH 2020 | Prof.Srdan Verstovsek: New drugs for myelofibrosis are emerging, and JAK inhibitors are promising